Population
123 consecutive patients with a history of sustained ventricular tachycardia or ventricular fibrillation
Design
Cohort
Authors
Loading...
Frequent adverse reactions with antiarrhythmics warrant selective use; hypothesis-generating and requires prospective validation before changing practice.
Clinically significant adverse reactions are common during antiarrhythmic drug therapy, indicating that these drugs should be reserved for patients at significant risk for symptomatic arrhythmias.
Thomas W. Nygaard (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: